The markets traded mixed during the midday with the Dow falling 38 points to 17,681 while Nasdaq gained 10 points to 4,748.
On the upside
Sunrun (Nasdaq: RUN) reversed year ago losses to post a greater than expected profit for the first quarter.
HTG Molecular Diagnostics (Nasdaq: HTGM) entered a research collaboration with Bristol-Myers Squibb (NYSE: BMY) to evaluate the potential for immuno-oncology molecular profiling in multiple tumor types.
On the downside
The Food and Drug Administration requested that Tetraphase Pharmaceuticals (Nasdaq: TTPH) conduct an additional phase 3 clinical trial to support its New Drug Application for IV eravacycline.
Bitauto Holdings (NYSE: BITA) fell to a greater than expected loss for the first quarter.
Petrobras (NYSE: PBR) fell to an unexpected loss for the first quarter.
Companhia Siderurgica Nacional (NYSE: SID) disappointed with a loss for the first quarter.
In the broad market, declining issues outpaced advancers by a margin of nearly 10 to 9 on the NYSE while advancers edged out decliners by a margin of more than 9 to 7 on Nasdaq. The broader S&P 500 slipped 2 points to 2,061. Bitcoin added $1 to $453.
